LINC00511, which is selectively overexpressed in NSCLC patients, can function as a ceRNA for miR-98-5p, another negative regulator of TGFBR1 mRNA expression, thus making LINC00511 an activator of pro-oncogenic TGF-β signaling in NSCLC (48). Here, LINC00511 is linked to non-small cell lung carcinoma.